Erichsen M, Løvås K, Skinningsrud B, et. al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency:observations from a N orwegian Registry. J Clin Endocrinol Metab 2009; 94(12): 4882–4890.
Willis A, Vince F. The prevalence of Addison’s disease in Coventry, UK . Postgrad Med Jr 1997; 73: 286–288.
Nieman L. Causes of primary adrenal insufficiency (Addison’s disease). Topic 166 Version 4.0. 2013 Jan. [cyt: 11.01.2013] Dostępny na: www.uptodate.com.
Barker JM, Ide A, Hostetler C, et al. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison’s disease in a high-risk population. J Clin Endocrinol Metab 2005; 90(1): 128.
Bednarek-Tupikowska G. Niedoczynność kory nadnerczy. W: Milewicz A, red. Endokrynologia kliniczna. Wrocław: Uniwersytet Medyczny 2013 (w druku).
Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361(31): 1881–1893.
Nieman L. Clinical manifestations of adrenal insufficiency in adults. Topic 159 Version 6.0. 2012 Dec. [cyt. 11.01.2013] Dostępny na: www.uptodate.com.
Nieman L. Diagnosis of adrenal insufficiency in adults. Topic 154 Version 12.0. 2012 Dec. [cyt. 11.01.2013] Dostępny na: www.uptodate.com.
Johannson G, Nilsson AG, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency:a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 2012 Feb; 97(2):473–481.
Lynette K, Nieman L. Treatment of adrenal insufficiency in adults. Topic 155 Version 8.0. Dec 2012. [cyt. 11.01.2013] Dostępny na: www.uptodate.com.
Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 2009; 94(4):1059–1067.
Arlt W. Adrenal insufficiency Clin Med 2008; 8: 211–215.
Hahner S, Allolio B. Therapeutic management of adrenal insufficiency Best Pract Res Clin Endocrinol Metabol 2009, 23:167–179.